IP Library Granted Patent US 11,639,342
Granted Patent B2
US 11,639,342 · App. 16/740,153 · Granted May 2, 2023

1,3-dipolar cycloadditions, and Staudinger ligations for conjugating biomolecules using click chemistry

Inventors: Andrei Polukhtin (Scottsdale, AZ); Peter J. An (Scottsdale, AZ); Alexandra Kulyashova (Scottsdale, AZ); Jakub M. Labedz (Scottsdale, AZ); Valentin A. Rassadin (Scottsdale, AZ); Nikita V. Savelyev (Scottsdale, AZ); Kostiantyn Ziabrev (Scottsdale, AZ)
Assignee: BIOCONJUGATE TECHNOLOGIES, LLC
C07D401/14C07D249/04C07D403/12C07D403/14C07D405/12C07D405/14C07D491/147G01N33/54306
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,639,342
App. No.
16/740,153
Granted
May 2, 2023
Kind
B2
Abstract

Compositions, methods, and kits for the labeling, detecting, isolating and/or analysis of biomolecules modified by attachment of chemical handles are disclosed. These embodiments involve a compound of the formula:

Claims (21)

1. A compound of the formula:

wherein:

n=0, 1, 2, 3 or 4

R 2 is a hydrogen, alkyl, or alkyl-SO 3 A,

where A is H or counterion,

R 1 comprises X-L-, wherein:

X is a reporter molecule, a solid support, a carboxylic acid, an activated ester of carboxylic acid, an amine, a hydrazine, a haloacetamide, an alky halide, an isothiocynate, or a maleimide group,

L is a single covalent bond or L is a covalent linkage having 1-24 non-hydrogen atoms selected from C, N, O, P and S and composed of any combinations of single, double, triple or aromatic carbon-carbon bonds, carbon-nitrogen bonds, nitrogen-nitrogen bonds, carbon-oxygen bonds, carbon-sulfur bonds, phosphorus-oxygen bonds and phosphorus-nitrogen bonds in the form of alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, alkoxy, substituted alkoxy, substituted alkyl, substituted heteroalkyl, substituted cycloalkyl, substituted heterocycloalkyl, aryl, heteroaryl, substituted aryl, arylalkyl, substituted arylalkyl, and substituted heteroaryl.

2. The compound of claim 1 wherein the reporter molecule comprises at least one of a fluorophore, a chromophore, a fluorescent protein, a phosphorescent dye, or a tandem dye.

3. The compound of claim 1 wherein the reporter molecule is xanthene, coumarine, cyanine, pyrene, oxazine, borapolyazaindacene, or carbopyranine.

4. The compound of claim 1 wherein the reporter molecule is a biotin.

5. The compound of claim 1 wherein the solid support is an aerogel, hydrogel, a resin, a silica gel, a bead, a biochip, a microfluidic chip, a silicon ship, a multi-well plate, a membrane, a polymeric membrane, a particle, a derivatized plastic film, a glass bead, a plastic bead, alumina gel, polysaccharide, poly(acrylate), polystyrene, poly(acrylamide), agarose, agar, cellulose, dextrain, starch, heparin, glycogen, amylopectin, nitrocellulose, polyvinylchloride, polypropylene, polyethylene, nylon, latex bead, magnetic bead, paramagnetic bead, superparamagnetic bead, or a magnetic support.

6. A method of modifying a biomolecule comprising the step of reacting a solution of biomolecule comprising an alkyne moiety with a compound of claim 1 to provide a modified biomolecule.

7. The method of claim 6 , wherein the solution further comprises copper ions.

8. The method according to claim 6 , wherein the method further comprises at least one reducing agent.

9. The method according to claim 6 , wherein the method further comprises a copper chelator.

10. A kit comprising a compound of claim 1 .

11. The kit of claim 10 , wherein the kit comprises a copper ion source.

12. The kit of claim 10 wherein the kit further comprises at least one reducing agent.

13. The kit of claim 10 , wherein the kit further comprises a copper chelator.

14. A compound selected from:

Assignments (3)
SECURITY INTEREST Recorded Jun 7, 2024
From: BIOCONJUGATE TECHNOLOGIES, LLC
To: AUDAX PRIVATE DEBT LLC, AS AGENT
Reel/Frame 067659/0979 →
SECURITY INTEREST Recorded Mar 31, 2023
From: BIOCONJUGATE TECHNOLOGIES, LLC
To: AUDAX PRIVATE DEBT LLC, AS AGENT
Reel/Frame 063182/0921 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2020
From: POLUKHTIN, ANDREI; AN, PETER J.; KULYASHOVA, ALEXANDRA; LABEDZ, JAKUB M.; RASSADIN, VALENTIN A.; SAVELYEV, NIKITA V.; ZIABREV, KOSTIANTYN
To: BIOCONJUGATE TECHNOLOGIES, LLC
Reel/Frame 051519/0072 →
Continuity (1)
Related Publication 20210214338A1 · Jul 15, 2021